SCHEDULE: Glenview Capital Sells Butterfly Network Stake

Glenview Capital Management and Larry Robbins have significantly reduced their holdings in Butterfly Network, Inc., selling millions of shares in recent transactions.

Summary

• Glenview Capital Management, LLC and Larry Robbins have filed an amendment to their Schedule 13D, reporting changes in their beneficial ownership of Butterfly Network, Inc. (BFLY) Class A common stock.
• As of August 13, 2026, Glenview Capital Management ceased to be the beneficial owner of more than five percent of the class of securities.
• Larry Robbins, as of the same date, beneficially owns 15,120,314 shares, representing 6.17% of the class of securities.
• This filing is an amendment to a previous Schedule 13D, with this being Amendment No. 8.
• The filing details various transactions where Glenview Funds, Longview Investors LLC, and Mr. Robbins sold shares of common stock through open market transactions between July 31, 2026, and August 17, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to significant share sales by major holders, indicating a potential lack of confidence or a strategic shift away from the company.

Negatives

• Glenview Capital Management, LLC is no longer a beneficial owner of more than five percent of Butterfly Network's common stock as of August 13, 2026.
• Significant sales of Butterfly Network stock by Glenview Funds and Longview Investors LLC occurred between July 31, 2026, and August 17, 2026.
• These sales include over 1.2 million shares by GCM Onshore Investors, L.P. and GCM Cayman Investors, Ltd. on July 31, 2026, at a weighted average price of $7.3925.
• Further sales by Glenview Offshore Opportunity Master Fund and Glenview Healthcare Master Fund on August 13, 2026, totaled over 715,000 shares.
• Longview Investors LLC also sold substantial amounts, with over 1.5 million shares sold between August 13, 2026, and August 17, 2026.

Risks

• The significant selling activity by major shareholders like Glenview Capital Management and Larry Robbins could signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment and stock price.
• The substantial volume of shares sold in open market transactions may exert downward pressure on the stock price.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company. However, the significant selling activity by major holders may imply a negative outlook from their perspective.

Management Comments

• Mr. Robbins has the right to acquire upon exercise of stock options 21,645 shares of Common Stock.
• Mr. Robbins has underlying unvested restricted stock units that vest in full on the date of the Issuer's 2027 Annual Stockholders Meeting, subject to his continued service on the Issuer's board of directors.

Industry Context

StockSavvy.ai notes that significant divestments by large institutional investors like Glenview Capital Management can be interpreted as a signal of reduced conviction in a company's growth trajectory or a strategic reallocation of capital. This is particularly relevant in the medical technology sector, which can be subject to rapid innovation cycles and regulatory hurdles.

Stakeholder Impact

• Shareholders may experience negative sentiment and potential stock price decline due to the significant selling by major holders.
• Employees may face uncertainty regarding the company's future direction if the selling indicates a lack of confidence from key investors.
• Creditors and suppliers may assess the company's stability based on the actions of significant investors.

Next Steps

• Glenview Capital Management will continue to monitor its holdings and may engage in further transactions.
• Larry Robbins will continue to serve on the Issuer's board of directors, with his unvested restricted stock units vesting on the date of the Issuer's 2027 Annual Stockholders Meeting.
• The company's future performance will be subject to market conditions and its ability to execute its business strategy.

Key Dates

Recommendation

The significant selling by Glenview Capital Management and Larry Robbins, while negative, does not necessarily indicate a fundamental deterioration of the company's long-term prospects. Larry Robbins still holds a substantial stake and remains on the board. The recommendation is 'hold' as the market may have already priced in some of this selling pressure, and further information on the company's operational performance is needed for a more definitive stance.

Keywords

Butterfly Network, Glenview Capital Management, Larry Robbins, Schedule 13D, Beneficial Ownership, Stock Sales, Insider Trading, Investment Management